April 6, 2021 - March 31, 2026 - Evolution and inhibition of carbapenemase in beta-lactam resistance , Co-Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01AI161762
April 1, 2021 - March 31, 2026 - Understanding Efficacy and Fe(II)-Promoted Activation of 1,2,4-Trioxolanes in Cancer , Co-Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01CA260860
July 1, 2021 - March 31, 2025 - Developing a pretargeting strategy to detect Fe(II) for nuclear medicine applications , Co-Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01EB029429
May 29, 2013 - August 31, 2023 - Chemical Methods for Ferrous Iron Dependent Drug Delivery , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01AI105106
February 1, 2019 - January 31, 2021 - Discovery of Novel Antimalarial Leads Targeting Translational Repression in Plasmodium parasites , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R21AI135495
March 1, 2018 - January 31, 2021 - Expanding the Chemical Biology of K2P Channels with Selective Cellular and In vivo Probes , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01MH116278
December 4, 2017 - November 30, 2019 - Biophysical Fragment Screening and Structure Determination for Class A, B, and D Carbapenemases , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R21AI135489
March 1, 2011 - February 28, 2013 - Chemical Methods for Ferrous Iron Targeted Drug Delivery , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R21AI094433
January 1, 2009 - December 31, 2011 - Identification of Anti-HIV Lead Compounds Targeting Rev , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R41AI076087